Italian Medicines Agency Agenzia Italiana del Farmaco

Innovation and planning

Innovation and planning

Timely access to technological innovations is one of the challenges the entire health system is facing.

AIFA, like all the regulators, considers scientific and technological progress applied to product development a priority for its actions.

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

Causalità e casualità nei recenti segnali di farmacovigilanza dei vaccini Covid-19

Go to YouTube channel

go to beginning of content